Who we are
The Innovative Clinical and Outcomes Research (iCOR) team is a hub of cutting-edge clinical research at the Thomas J. Long School of Pharmacy. iCOR provides opportunities for students to collaborate with peers, faculty, fellows and industry pharmacists on high-impact research projects. The team is led by accomplished faculty members who are leading experts in their fields and is supported by an impressive network of successful alumni who are now leaders in industry.
What we do
As trailblazers in the medical device and dietary supplement space, the iCOR team spearheads innovative research projects and clinical trials to deliver consequential findings that impact patient care and the scientific community. We engage in innovative projects which use existing data or data collected by recruiting more than 100 volunteers. We focus on studies which can be conducted rapidly, between six months and two years. Completed projects have ranged from proof-of-concepts to studies validating causality. iCOR conducts research in collaboration with the Fellowship in Industry Program, which includes partnerships with Day One, BeOne, Genentech, Gilead, BridgeBio and the United States Air Force.
Where we’re going
Building on extensive research and previous work, iCOR continues to pioneer innovative research through a robust pipeline of ongoing research programs, including research on continuous glucose monitoring devices and enhanced external counter pulsation treatments. Through continuous evaluation of the current industry landscape, iCOR’s research focus stays ahead of the curve. In addition, the team seeks to continue to strategically develop working relationships with leading pharmaceutical and biotechnology companies.
Media impressions
Posters/publications
Clinical trials
We strive to advance patient care through innovative research. Our goal is to train students and prepare them to become leaders in the pharmaceutical industry by providing rich learning experiences, leadership opportunities and mentorship.
What started as a passion project for one student to pursue the pharmaceutical industry pathway has grown into a track for students to excel in this arena. As iCOR has grown over the years, the scope of the projects conducted by its members have also expanded. The work of our students, faculty and alumni has been nationally recognized through numerous publications and presentations. Our projects illustrate the classic interplay between science and scientists, a cat-and-mouse game in the pursuit of optimizing human health.
Class of 2025
- , PharmD – Clinical Science Fellow at Daiichi Sankyo
- , PharmD – Clinical Operations Fellow at Gilead
- , PharmD – Medical Affairs Fellow at Rocket Pharmaceuticals
- , PharmD – Medical Affairs Fellow at Intercept Pharmaceuticals
Class of 2024
- , PharmD - Clinical Trial Project Management Fellow at Eli Lilly
- , PharmD - Clinical Pharmacology Fellow at Vertex Pharmaceuticals
- , PharmD - Clinical Science & Operations Fellow at Sanofi
- , PharmD - Pharmacy Manager at Sutter Care
- , PharmD - Medical Affairs / Strategy Fellow in Diabetes at Sanofi
- , PharmD - Pharmacovigilance Operations Associate at Genentech
Class of 2023
- , PharmD - Clinical Operations Fellow at Genentech
- , PharmD - Clinical Pharmacology Fellow at Boehringer Ingelheim
- , PharmD - Clinical Operations Fellow at Gilead
- , PharmD – Clinical Development Fellow at Sumitomo Pharma
Class of 2022
- , PharmD - Clinical Science Fellow at Genentech
- , PharmD - Oncology Drug Safety Fellow at Seagen
- , PharmD - Regulatory Affairs: Advertising and Promotion Fellow at Merck
- , PharmD - Clinical Development Fellow at Pfizer
- - Global Medical Information Fellow at Gilead
- - Regulatory Affairs Fellow at Novartis
- - PharmD/ PhD Candidate at sky casino genting
Class of 2021
- , PharmD - Clinical Research and Drug Development Fellow at UNC
- , PharmD - Biologics Associate at Regeneron
- , PharmD - US Marketing and Global Commercial Strategy, Rare Diseases at Sanofi Genzyme
- , PharmD - Global Medical Affairs: Inflammation and Immunology Fellow at Pfizer
- Brandon Tran, PharmD - Clinical Operations at Genentech
- , PharmD - Manager, Quantitative Clinical Pharmacology at Daiichi Sankyo
Class of 2020
- , PharmD - Clinical Biosample Coordinator at Astex Pharmaceuticals
- , PharmD - Clinical Pharmacology Fellow at AbbVie
- , PharmD - PGY1 Pharmacy Resident
- , PharmD - Clinical Science & Study Management Fellow at Merck
- , PharmD - Medical Affairs Specialist - Consultant at Rigel Pharmaceuticals
- , PharmD - Medical Consultant at GoRN
- Erica Su, PharmD - Clinical Development Fellow at Allergan
Class of 2019
- , PharmD - PGY1 Managed Care Pharmacy Resident
- , PharmD - Clinical Science Fellow at Genentech
- , PharmD - Drug Development and Clinical Research Fellow at PPD
- , PharmD - Clinical Science Fellow at Acerta Pharma
Class of 2018
- , PharmD - Global Clinical Research and Development Fellow at Pfizer
- , PharmD - Clinical Scientist Fellow at Novartis
- , PharmD - Clinical Trial Associate at BioMarin
- , PharmD - PGY1 Managed Care Pharmacy Resident
- , PharmD - Product Development Fellow at United Therapeutics Corporation
Class of 2017
- , PharmD - Regulatory Affairs Fellow at Celgene
- , PharmD - Medical Affairs Fellow at Amgen
- , PharmD - Clinical Trial Manager Fellow at Eli Lilly
Class of 2016
- , PharmD - Clinical Innovation Fellow at Eli Lilly
- , PharmD - Regulatory Affairs Fellow at Biogen
- , PharmD - Associate Medical Writer at ApotheCom
- , PharmD - Staff Pharmacist at CVS Pharmacy
Class of 2015
- , PharmD - Pharmacy Practice Fellow at sky casino genting
Class of 2014
- , PharmD - Clinical Science Fellow at Roche
- , PharmD - Commercial Development and Access Strategy Fellow at Medimix Specialty Pharmacy
Class of 2013
- , PharmD - Clinical Science Fellow at Roche
Class of 2012
- , PharmD - Clinical Development Fellow at Novartis
Class of 2011
- , PharmD - Drug Information and Evidence-Based Practice Fellow at Creighton University
50+ alumni making an impact in the pharmaceutical industry
Hear how iCOR has shaped their educational journey
“In iCOR, my peers and I felt valued like family, and our professional goals were heard and prioritized. The mentors are attentive and invested in our growth, providing resources and support to develop us into leaders with influence and impact in any professional journey we pursue.”
— Jenifer Pham ’24, PharmD
US Medical Affairs / Strategy Fellow at Sanofi
"iCOR had a profound impact on my journey through pharmacy school. The collaborative relationship between faculty and students of iCOR creates an environment that combines critical thinking and science, and ultimately maximizes patient outcomes. I got the opportunity to conduct literature review, design and execute clinical trials, and summarize the resulting data in manuscripts. It helped me realize my passion for pursuing a career in clinical development within the pharmaceutical industry."
— Ricky Philipossian ’22, PharmD
Clinical Development Fellow at Pfizer
“iCOR gave me the opportunity to continually challenge my critical thinking and broaden my perspective. My understanding of drug development deepened through hands-on experience with designing and executing the first virtual clinical trial at Pacific. I witnessed firsthand how vital research is in impacting and improving patient care. The skills and lessons I learned from the supportive mentorship and unique experiences in iCOR will stay with me throughout my career.”
— Kimmy Dovan ’22, PharmD
Regulatory Affairs: Advertising and Promotion Fellow at Merck
Notable Publications
Energy Drink
Continuous Glucose Monitoring (CGM) Studies
Enhanced External Counterpulsation (EECP)
Nutrition
Study shows glucose levels can be different between left and right arm
In a novel study, Pacific researchers found the selection of either the right or left arm for continuous glucose monitoring device placement could potentially affect the glucose readings collected by the devices.
Research shows health benefits of plant-based meal kits
Results of a clinical trial showed a statistically significant reduction in both “bad” cholesterol and body weight when volunteers ate dinners made from a plant-based meal kit service compared to a non-plant-based meal kit.
Research team tests hangover product
The team conducted a randomized, double-blind, placebo-controlled study to determine if the dietary supplement reduced hangover symptoms.
Connect with us for updates on our research initiatives and student contributions. Learn how you can get involved.
